Patent ID: 7812046
Filing Date: 2010-10-12
Classification: A61K,A61P

Abstract:
1. A method for treating hypertension and dyslipidemia in an individual, the method comprising orally administering to the individual (i) a fibrate and (ii) an effective amount of a compound that (a) at least partially activates peroxisome proliferator activated receptor-gamma (PPAR-γ), and (b) at least partially inhibits, antagonizes, or blocks an activity of angiotensin II type 1 receptors, wherein the effective amount of the compound that at least partially activates PPAR-γ and at least partially inhibits, antagonizes, or blocks an activity of angiotensin II type 1 receptors decreases serum triglycerides or LDL-cholesterol or increases HDL-cholesterol, and wherein the compound is telmisartan.